---
figid: PMC8686226__13045_2021_1218_Fig3_HTML
figtitle: Developing landscape of combinatorial therapies of immune checkpoint blockade
  with DNA damage repair inhibitors for the treatment of breast and ovarian cancers
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC8686226
filename: 13045_2021_1218_Fig3_HTML.jpg
figlink: /pmc/articles/PMC8686226/figure/Fig3/
number: F3
caption: Mechanisms of DDRi and ICB affecting PD‐L1 expression and TME in tumors with
  DDR deficiency. DNA damage amplified by DDRi activates cGAS/STING, DNA damage response,
  and neoantigen pathway, inducing PD-L1 expression, pro-inflammatory cytokines release
  and CTLs infiltration while reducing Tregs and exhausted T cells, which combines
  with ICB, leading to immune activation and immunogenic cell death. Cyclic GMP‐AMP
  synthase (cGAS); stimulator of interferon genes (STING); double-strand breaks (DSB);
  homologous recombination (HR); microsatellite instability (MSI); mismatch repair
  deficiency (MMRd); homologous recombination deficiency (HRD); breast cancer 1/2
  (BRCA1/2); DNA damage response (DDR); T cell receptor (TCR); programmed death‐ligand
  1 (PD‐L1); programmed death‐1(PD-1); cytotoxic T-lymphocyte-associated antigen 4
  (CTLA-4); cytotoxic CD8+ T cells (CTLs); tumor-necrosis factorα (TNFα); interferon
  γ(IFN γ); interferon alpha/beta receptor (IFNAR); interferon regulatory factors
  (IRFs); regulatory T cells (Tregs); immune checkpoint blockade (ICB); granulocytic/monocytic
  myeloid-derived suppressor cells (g/mMDSCs); poly-ADP-ribose polymerase (PARP);
  ataxia telangiectasia and Rad3-related protein (ATR); checkpoint kinase 1 (CHK1);
  effector T-cells (Teff)
papertitle: The developing landscape of combinatorial therapies of immune checkpoint
  blockade with DNA damage repair inhibitors for the treatment of breast and ovarian
  cancers.
reftext: Lingling Zhu, et al. J Hematol Oncol. 2021;14:206.
year: '2021'
doi: 10.1186/s13045-021-01218-8
journal_title: Journal of Hematology & Oncology
journal_nlm_ta: J Hematol Oncol
publisher_name: BioMed Central
keywords: Immune checkpoint blockade | Breast cancer | Ovarian cancer | DNA damage
  repair inhibitor
automl_pathway: 0.9539837
figid_alias: PMC8686226__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC8686226__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8686226__13045_2021_1218_Fig3_HTML.html
  '@type': Dataset
  description: Mechanisms of DDRi and ICB affecting PD‐L1 expression and TME in tumors
    with DDR deficiency. DNA damage amplified by DDRi activates cGAS/STING, DNA damage
    response, and neoantigen pathway, inducing PD-L1 expression, pro-inflammatory
    cytokines release and CTLs infiltration while reducing Tregs and exhausted T cells,
    which combines with ICB, leading to immune activation and immunogenic cell death.
    Cyclic GMP‐AMP synthase (cGAS); stimulator of interferon genes (STING); double-strand
    breaks (DSB); homologous recombination (HR); microsatellite instability (MSI);
    mismatch repair deficiency (MMRd); homologous recombination deficiency (HRD);
    breast cancer 1/2 (BRCA1/2); DNA damage response (DDR); T cell receptor (TCR);
    programmed death‐ligand 1 (PD‐L1); programmed death‐1(PD-1); cytotoxic T-lymphocyte-associated
    antigen 4 (CTLA-4); cytotoxic CD8+ T cells (CTLs); tumor-necrosis factorα (TNFα);
    interferon γ(IFN γ); interferon alpha/beta receptor (IFNAR); interferon regulatory
    factors (IRFs); regulatory T cells (Tregs); immune checkpoint blockade (ICB);
    granulocytic/monocytic myeloid-derived suppressor cells (g/mMDSCs); poly-ADP-ribose
    polymerase (PARP); ataxia telangiectasia and Rad3-related protein (ATR); checkpoint
    kinase 1 (CHK1); effector T-cells (Teff)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cgas
  - Sting1
  - Parp1
  - Tbk1
  - Nfkb1
  - Irf3
  - Ifnb1
  - Ccl3
  - Ifna
  - Csf2ra
  - Havcr2
  - Atm
  - Tpm1
  - Chek1
  - Atr
  - Mmab
  - Cd274
  - Ctla4
  - Ebp
  - Brca1
  - Ifng
  - Trav6-3
  - CGAS
  - STING1
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - NFKB1
  - IRF3
  - IFNA1
  - IFNB1
  - CCL3
  - IFN1@
  - IFNA2
  - IFNA17
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - CSF2RA
  - HAVCR2
  - ATM
  - CHEK1
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - FOXG1
  - FOXH1
  - FOXM1
  - FOXQ1
  - FOXS1
  - FOXA1
  - FOXA2
  - FOXA3
  - FOXB1
  - FOXB2
  - FOXC1
  - FOXC2
  - FOXD1
  - FOXD2
  - FOXD3
  - FOXD4
  - FOXE1
  - FOXE3
  - FOXF1
  - FOXF2
  - FOXI1
  - FOXI2
  - FOXI3
  - FOXJ1
  - FOXJ2
  - FOXJ3
  - FOXK1
  - FOXK2
  - FOXL1
  - FOXL2
  - FOXN1
  - FOXN2
  - FOXN3
  - FOXN4
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - FOXP1
  - FOXP2
  - FOXP3
  - FOXP4
  - FOXR1
  - FOXR2
  - FOXD4L1
  - FOXD4L3
  - FOXD4L4
  - FOXD4L5
  - FOXD4L6
  - CD274
  - CTLA4
  - TBCE
  - DDR1
  - DDR2
  - BRCA1
  - IFNG
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
---
